Continuation Rates of the Etonogestrel Implant and Factors Associated With Early Discontinuation

Background: The etonogestrel implant is generally considered an effective, three-year, long-acting reversible contraceptive device. Previous research, such as the landmark CHOICE study, has reported a one-year continuation rate of 72% to 84%, however, in a real-world setting these rates may be signi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hines, Genesis, Wang, Carrie, Walker, Treasure, Jereen, Amyeo, Quinones, Joanne N, Waxman, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Obstetrics/Gynecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102878/
https://www.ncbi.nlm.nih.gov/pubmed/37065304
http://dx.doi.org/10.7759/cureus.36117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102878/
https://www.ncbi.nlm.nih.gov/pubmed/37065304
http://dx.doi.org/10.7759/cureus.36117

Ejemplares similares